Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
23%

OVERLAP
BY WEIGHT
11

# OF OVERLAPPING
HOLDINGS
CANC
50
HOLDINGS
22%
ALSO IN IDNA
IDNA
44
HOLDINGS
29%
ALSO IN CANC
SECTOR DRIFT (CANC minus IDNA)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in IDNA
Overlap
ASTRAZENECA PLC 4.4% 4.3% 4.3%
REVOLUTION MEDICINES, INC. 5.3% 3.5% 3.5%
ARCELLX, INC. 3.1% 4.1% 3.1%
EXELIXIS INC 3.1% 3.5% 3.1%
MERCK & CO. INC. 2.3% 4.3% 2.3%
CANC Overweight Relative to IDNA
BRIDGEBIO PHARMA, INC. 5.1%
ROCHE HOLDINGS LTD-SPONS ADR 4.9%
NOVARTIS AG 4.6%
MERUS N.V. 4.4%
GENMAB A/S SPONSORED ADR 4.1%
ELI LILLY & CO 3.8%
BEIGENE LTD. SPONSORED ADR 3.1%
NUVALENT, INC. CLASS A 3.1%
SUMMIT THERAPEUTICS INC 3.1%
BRISTOL-MYERS SQUIBB CO 3.1%
CANC Underweight Relative to IDNA
INCYTE CORP -4.8%
GENMAB A/S -4.3%
TAKEDA PHARMACEUTICAL CO LTD -4.1%
BIONTECH SE SPONSORED ADR -4.0%
SANOFI-AVENTIS -4.0%
ROCHE HOLDING LTD -3.9%
MODERNA, INC. -3.8%
GSK PLC -3.8%
TWIST BIOSCIENCE CORP. -3.5%
REGENERON PHARMACEUTICALS -3.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY